165 related articles for article (PubMed ID: 7578125)
1. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated aromatic inhibitors of HIV-1 integrase.
Burke TR; Fesen MR; Mazumder A; Wang J; Carothers AM; Grunberger D; Driscoll J; Kohn K; Pommier Y
J Med Chem; 1995 Oct; 38(21):4171-8. PubMed ID: 7473544
[TBL] [Abstract][Full Text] [Related]
4. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.
Fesen MR; Pommier Y; Leteurtre F; Hiroguchi S; Yung J; Kohn KW
Biochem Pharmacol; 1994 Aug; 48(3):595-608. PubMed ID: 7520698
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex.
Mazumder A; Gupta M; Perrin DM; Sigman DS; Rabinovitz M; Pommier Y
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):115-25. PubMed ID: 7734185
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of human immunodeficiency virus integrase.
Fesen MR; Kohn KW; Leteurtre F; Pommier Y
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2399-403. PubMed ID: 8460151
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type-1 integrase by curcumin.
Mazumder A; Raghavan K; Weinstein J; Kohn KW; Pommier Y
Biochem Pharmacol; 1995 Apr; 49(8):1165-70. PubMed ID: 7748198
[TBL] [Abstract][Full Text] [Related]
10. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.
Eich E; Pertz H; Kaloga M; Schulz J; Fesen MR; Mazumder A; Pommier Y
J Med Chem; 1996 Jan; 39(1):86-95. PubMed ID: 8568830
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures.
Mazumder A; Neamati N; Ojwang JO; Sunder S; Rando RF; Pommier Y
Biochemistry; 1996 Oct; 35(43):13762-71. PubMed ID: 8901518
[TBL] [Abstract][Full Text] [Related]
12. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.
Engelman A; Hickman AB; Craigie R
J Virol; 1994 Sep; 68(9):5911-7. PubMed ID: 8057470
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
Robinson WE; Reinecke MG; Abdel-Malek S; Jia Q; Chow SA
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6326-31. PubMed ID: 8692814
[TBL] [Abstract][Full Text] [Related]
14. Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates.
Chow SA; Brown PO
J Virol; 1994 Jun; 68(6):3896-907. PubMed ID: 8189526
[TBL] [Abstract][Full Text] [Related]
15. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.
Jenkins TM; Hickman AB; Dyda F; Ghirlando R; Davies DR; Craigie R
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6057-61. PubMed ID: 7597080
[TBL] [Abstract][Full Text] [Related]
16. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.
Wolfe AL; Felock PJ; Hastings JC; Blau CU; Hazuda DJ
J Virol; 1996 Mar; 70(3):1424-32. PubMed ID: 8627659
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide binding by the HIV-1 integrase protein in vitro.
Lipford JR; Worland ST; Farnet CM
J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1215-23. PubMed ID: 7965631
[TBL] [Abstract][Full Text] [Related]
18. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules.
Farnet CM; Wang B; Lipford JR; Bushman FD
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9742-7. PubMed ID: 8790401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
